Skip to main content
. 2017 Aug 1;13:35. doi: 10.1186/s13223-017-0207-8

Table 4.

Subjects for analysis of ILTN-1 mRNA pre or post ICS treatment

N (distal: proximal) Age M:F FEV1/FVC (%) %FEV1 (%) FeNO (ppb) ICS (µg)
ST-Asthma (post treatment) 6 (3:3) 65 ± 4 3:0 69 ± 4 84 ± 4 51 ± 4 400
SN-Asthma (pre treatment) 6 (3:3) 65 ± 4 3:0 68 ± 4 89 ± 4 171 ± 49*** 0

***p < 0.05 vs ST-Asthma